Cargando…

Gender associated differences in determinants of quality of life in patients with COPD: a case series study

BACKGROUND: The influence of gender on the expression of COPD has received limited attention. Quality of Life (QoL) has become an important outcome in COPD patients. The aim of our study was to explore factors contributing to gender differences in Quality of Life of COPD patients. METHODS: In 146 me...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Torres, Juan P, Casanova, Ciro, Hernández, Concepción, Abreu, Juan, Montejo de Garcini, Angela, Aguirre-Jaime, Armando, Celli, Bartolome R
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592076/ https://www.ncbi.nlm.nih.gov/pubmed/17007639 http://dx.doi.org/10.1186/1477-7525-4-72

Ejemplares similares

COPD heterogeneity: Gender differences in the multidimensional BODE index
por: de Torres, Juan P, et al.
Publicado: (2007)

Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease
por: de Torres, Juan P, et al.
Publicado: (2007)

Gender Differences in Plasma Biomarker Levels in a Cohort of COPD Patients: A Pilot Study
por: de Torres, Juan P., et al.
Publicado: (2011)

Telomere shortening and accelerated aging in COPD: findings from the BODE cohort
por: Elizabeth, Córdoba-Lanús, et al.
Publicado: (2017)

Erratum to: Telomere shortening and accelerated aging in COPD: findings from the BODE cohort
por: Cordoba-Lanus, Elizabeth, et al.
Publicado: (2017)

Pulmonary arterial enlargement predicts long-term survival in COPD patients
por: de-Torres, Juan P., et al.
Publicado: (2018)

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients
por: López-Campos, José Luis, et al.
Publicado: (2020)

Is COPD a Progressive Disease? A Long Term Bode Cohort Observation
por: de-Torres, Juan P., et al.
Publicado: (2016)

Chest CT‐assessed comorbidities and all‐cause mortality risk in COPD patients in the BODE cohort
por: Ezponda, Ana, et al.
Publicado: (2022)

Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD
por: Pinto-Plata, Victor, et al.
Publicado: (2012)

Finding the Best Thresholds of FEV(1) and Dyspnea to Predict 5-Year Survival in COPD Patients: The COCOMICS Study
por: Almagro, Pere, et al.
Publicado: (2014)

Prospective comparison of non-invasive risk markers of major cardiovascular events in COPD patients
por: Zagaceta, Jorge, et al.
Publicado: (2017)

Plasma metabolomics and clinical predictors of survival differences in COPD patients
por: Pinto-Plata, Victor, et al.
Publicado: (2019)

Role of HIF1A, VEGFA and VEGFR2 SNPs in the Susceptibility and Progression of COPD in a Spanish Population
por: Baz-Dávila, Rebeca, et al.
Publicado: (2016)

Recommendations for the early diagnosis of COPD: the AIMAR view
por: Celli, Bartolome R
Publicado: (2015)

COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series)
por: Polverino, Francesca, et al.
Publicado: (2018)

Natural history of COPD: gaps and opportunities
por: Agustí, Alvar, et al.
Publicado: (2017)

Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study
por: Cabrera, Carlos, et al.
Publicado: (2016)

COPD: time to improve its taxonomy?
por: Celli, Bartolomé R., et al.
Publicado: (2018)

Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort
por: Divo, Miguel J., et al.
Publicado: (2018)

Somatotypes trajectories during adulthood and their association with COPD phenotypes
por: Divo, Miguel J., et al.
Publicado: (2020)

Venous Admixture in COPD: Pathophysiology and Therapeutic Approaches
por: Cooper, Christopher B., et al.
Publicado: (2009)

Selecting the Right Patient: The Achilles Heel of COPD Clinical Trials
por: Polverino, Francesca, et al.
Publicado: (2022)

Increased expression of A Proliferation-inducing Ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: a possible link between COPD and lung cancer?
por: Polverino, Francesca, et al.
Publicado: (2016)

Nocturnal Hypoxemia and CT Determined Pulmonary Artery Enlargement in Smokers
por: Marin-Oto, Marta, et al.
Publicado: (2021)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
por: Halpin, David MG, et al.
Publicado: (2017)

Exacerbation frequency and course of COPD
por: Halpin, David MG, et al.
Publicado: (2012)

The BODECOST Index (BCI): a composite index for assessing the impact of COPD in real life
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change
por: Jones, Paul W, et al.
Publicado: (2011)

Unravelling young COPD and pre-COPD in the general population
por: Cosío, Borja G., et al.
Publicado: (2023)

From pre-COPD to COPD: a Simple, Low cost and easy to IMplement (SLIM) risk calculator
por: Divo, Miguel J., et al.
Publicado: (2023)

Prognostic assessment in COPD without lung function: the B-AE-D indices
por: Boeck, Lucas, et al.
Publicado: (2016)

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
por: Vanfleteren, Lowie, et al.
Publicado: (2018)

Sexually-dimorphic targeting of functionally-related genes in COPD
por: Glass, Kimberly, et al.
Publicado: (2014)

Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease
por: Divo, Miguel J., et al.
Publicado: (2022)

Introducción al tratamiento de series temporales : aplicación a las ciencias de la salud
por: Aguirre Jaime, Armando
Publicado: (1994)

TNFA-863 polymorphism is associated with a reduced risk of Chronic Obstructive Pulmonary Disease: A replication study
por: Córdoba-Lanús, Elizabeth, et al.
Publicado: (2011)

Associations between serum mitokine levels and outcomes in stable COPD: an observational prospective study
por: Amado, Carlos A., et al.
Publicado: (2022)

Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study
por: Miravitlles, Marc, et al.
Publicado: (2022)

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_c090845npo3t2maforrs7c9nco